Detalles de la búsqueda
1.
Y90 -Ibritumomab tiuxetan (Y90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05).
Hematol Oncol
; 35(4): 576-583, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677906
2.
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
Br J Haematol
; 174(2): 255-63, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27018242
3.
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.
Eur Urol Oncol
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38664139
4.
An in vivo study of a growth-factor enhanced, cell free, two-layered collagen-tricalcium phosphate in deep osteochondral defects.
Biomaterials
; 27(18): 3387-95, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16488472
5.
Complete subchondral bone defect regeneration with a tricalcium phosphate collagen implant and osteoinductive growth factors: a randomized controlled study in Göttingen minipigs.
J Biomed Mater Res B Appl Biomater
; 102(5): 933-42, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24259283
Resultados
1 -
5
de 5
1
Próxima >
>>